3M India

As of the close on 2026-11-05, 3MINDIA trades at ₹29,325.0, reflecting a -22.1% drawdown from its available high and an -18.5% year-to-date return. The daily technical structure is bearish: price remains below all key moving averages (EMA/SMA 20/50/200) and the Supertrend indicator, with an established downtrend confirmed by an ADX of 34.85. Momentum indicators show selling pressure dominating (Minus DI 23.73 vs Plus DI 15.12). Despite this, the stock posted a +1.7% gain on 2026-11-05, marked by a high-severity upward gap anomaly (z-score 3.71), suggesting short-term buying interest within the broader decline.

On higher timeframes, the monthly trend shows conflicting signals: while price is below moving averages, the Supertrend remains bullish, and an active Inside Bar pattern suggests consolidation. Weekly trends remain weak (ADX 18.26) and bearish. Key resistance lies near ₹29,481.67 (0.53% above), while immediate support rests at ₹29,158.33 (0.57% below). Annualized volatility stands at +28.6%, indicating significant price fluctuation risk.

On 6 November 2026, 3M India reported its Q2 FY2026 results, revealing a 17% decline in net profit. The company attributed this contraction to two primary headwinds: a weaker Indian rupee and rising input costs. Following the announcement, market participants reacted sharply, with shares tumbling by up to 11%. This development occurred during a broader quarterly earnings window that included other major listed entities such as Hindalco, Bosch, Siemens, and Titan, but 3M India’s specific financial deterioration and subsequent equity price volatility represent the most material event for investors in this seven-day period.

On November 6, 2026, 3M India reported unaudited financial results for the quarter and half-year ended September 30, 2026, revealing a divergence between top-line growth and profitability. Revenue grew 14.7% year-over-year to ₹1,452.49 crores, yet profit after tax declined 17.2% to ₹158.48 crores. The company attributed this margin compression to rupee depreciation and rising input costs. Following the announcement, shares tumbled up to 11%, with the price observed at ₹29,325 on November 5, 2026, compared to ₹28,835 previously.

Concurrently, the Board executed significant governance changes effective November 7, 2026. Mr. Chun Hao Lok was appointed as an Additional Director (Non-Executive, Non-Independent), subject to shareholder approval via postal ballot, while Ms. Kong Sau Wai Elizabeth resigned to pursue opportunities outside 3M. The Audit, Stakeholders Relationship, and Risk Management committees were also reconstructed. These developments mark a shift in both financial performance drivers and board composition.

3M India Limited reported unaudited financial results for the quarter and half-year ended September 30, 2026, on November 6, 2026. The company recorded a 14.7% year-over-year revenue growth to ₹1,452.49 crores (with Total Income at ₹1,463.66 crores), but Profit After Tax declined by 17.2% to ₹158.48 crores. Management attributed this profit contraction to rupee depreciation and input cost inflation.

Concurrently, the Board executed changes in its composition. Ms. Kong Sau Wai Elizabeth resigned as a Non-Executive Director effective November 6, 2026, to pursue opportunities outside 3M. Mr. Chun Hao Lok was appointed as an Additional Director (Non-Executive, Non-Independent) effective November 7, 2026, with a postal ballot initiated for shareholder approval of his permanent appointment. The Board also reconstructed its Audit, Stakeholders Relationship, and Risk Management committees.

In a separate development filed on October 26, 2026, the Board approved amendments to healthcare business agreements. These include extending the Distribution Agreement for continuing products by two years (to seven years from March 31, 2024) and removing certain divested products from the scope.

3M India demonstrates a robust operating trajectory with accelerating revenue growth and improving profitability in the most recent quarter. For Q1 FY2026-27, revenue from operations rose sequentially to ₹1,423.21 crore, while net profit increased to ₹233.07 crore from ₹215.34 crore in Q4 FY2025-26. This sequential improvement was driven by a reduction in other expenses to ₹173.49 crore, despite a marginal rise in finance costs to ₹3.98 crore.

On an annual basis, the company’s financial health remains strong, supported by high returns on capital. Return on Capital Employed (ROCE) improved significantly to 50% for Mar 2026, up from 38% in prior years, indicating efficient utilization of invested capital. However, earnings quality faces headwinds as cash conversion efficiency declined; CFO/EBITDA share dropped to 82% in Mar 2026 from 111% in Mar 2024. This is accompanied by a lengthening Cash Conversion Cycle to 60 days and rising borrowings, which increased to ₹170 crore in Mar 2026 from ₹18 crore in Mar 2024. While long-term compounded sales growth stands at 11% over three years, the trailing twelve months (TTM) saw a contraction in profit growth (-11%), highlighting a divergence between top-line expansion and bottom-line pressure in the near term.

3M India faces near-term headwinds from currency volatility and cost pressures, evidenced by a 17% decline in Q2 net profit attributed to a weaker rupee and rising input costs. This fundamental deterioration triggered a sharp market reaction, with shares tumbling up to 11% following the announcement. Technical indicators reinforce this caution: the daily Supertrend is bearish, supported by negative slopes across the 20-day EMA (-479.4), SMA 20 (-497.5), and SMA 50 (-489.1). The stock has underperformed significantly over longer horizons, recording a year-to-date return of -18.5% and a one-year return of -18.3%. Volatility remains elevated at an annualized 28.6%, with the price currently sitting 22.1% below its recent peak. While monthly trends remain bullish, the immediate daily and weekly momentum is clearly negative.